Inhibition of acetylation, is it enough to fight cancer?

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Acetylation is a reversible post-translational modification (PTM) regulating vital cellular functions like proliferation, DNA repair, and cell cycle progression.
• An imbalance in acetylation is linked to carcinogenesis, highlighting its significance in cancer development.
• Acetylation's role in cellular processes makes it a potential therapeutic target for anticancer strategies.

Purpose of the Study:

• To elucidate how acetylation regulates the cell cycle.
• To understand acetylation modifications in cancer cells.
• To identify key proteins involved in apoptosis induction for cancer therapy.

Main Methods:

• Review of existing literature on acetylation's role in cell cycle and cancer.
• Discussion of therapeutic compounds targeting acetylation.
• Exploration of acetylomics as a research tool.

Main Results:

• Acetylation critically influences cell cycle progression and DNA damage repair.
• Aberrant acetylation patterns are observed in cancer cells.
• Several proteins involved in apoptosis are regulated by acetylation, presenting therapeutic targets.
• Compounds like Curcumin and C646 demonstrate antitumor activity via acetylation inhibition.

Conclusions:

• Acetylation dysregulation is implicated in cancer, offering a target for novel therapies.
• Inhibiting acetylation shows promise as an anticancer strategy, with several compounds under investigation.
• Further research using acetylomics is needed to clarify acetylation's precise roles in gene expression and DNA stability in various cell types.